# Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX

Study · id `cardio:ct-nct01433627` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01433627](<https://clinicaltrials.gov/study/NCT01433627>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01433627

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 7200 participants.

## Technical summary

Registry record NCT01433627. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 7200 participants (planned count; ClinicalTrials.gov record NCT01433627, source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01433627, source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)
- Primary completion: 2014-11 (actual) (ClinicalTrials.gov record NCT01433627, source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01433627, source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01433627, source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01433627-2015-01-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX
- Acronym: MATRIX
- Condition: Acute Coronary Syndromes
- Condition: STEMI
- Condition: NSTEMI
- Intervention (Other): trans-radial and short-term bivalirudin
- Intervention (Other): trans-radial and long-term bivalirudin infusion
- Intervention (Other): trans-radial and standard of care pharmacology
- Intervention (Other): Trans-femoral and Short-term bivalirudin
- Intervention (Other): trans-femoral and long-term bivalirudin infusion
- Intervention (Other): trans-femoral and standard of care pharmacology
- Lead sponsor: Italian Society of Invasive Cardiology
- Lead sponsor class: OTHER
- Collaborator: Eustrategy
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Italian Society of Invasive Cardiology (`cardio:org-italian-society-of-invasive-cardiology`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial (`cardio:pubmed-25791214`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes (`cardio:pubmed-26324049`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study (`cardio:pubmed-25854692`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial (`cardio:pubmed-29301646`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes (`cardio:pubmed-29544607`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial (`cardio:pubmed-30153988`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome (`cardio:pubmed-30784669`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Choice of access site and type of anticoagulant in acute coronary syndromes with advanced Killip class or out-of-hospital cardiac arrest (`cardio:pubmed-32151464`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes (`cardio:pubmed-33509394`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management (`cardio:pubmed-33602431`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ultra-Short Term Evaluation of Coronary Vessel Wall Changes in Reference Segments Adjacent to Culprit Lesions in ST-Segment Elevation Myocardial Infarction (`cardio:pubmed-34792483`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial (`cardio:pubmed-34491323`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome (`cardio:pubmed-41065238`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prognostic Implications of Evolving Universal Definitions of Periprocedural Myocardial Infarction in Patients With Acute Coronary Syndrome (`cardio:pubmed-41493005`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bd213ae1d3b77a1a1182f0c448ec7b1645187416791af9c62741db75c15bd241
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
